ZUP1 and non-small cell lung carcinoma: Notably, DUB-mediated deubiquitination has emerged as a crucial regulatory mechanism in NSCLC pathogenesis, with accumulating evidence supporting its roles in modulating key oncogenic pathways and therapeutic resistance.